Although the molecular mechanisms underlying cancer metastasis remain to be fully elucidated, accumulating evidence points on a significant role of CXCL12/CXCR4 in the process [32–35], suggesting that the CXCL12/CXCR4 axis may be a potential therapeutic target in BC. Here, CXCR4 is linked to breast cancer.